AJH Terveys Oy is a limited company based in Tampere, registered in 2021. In the financial year ending 31.10.2025, revenue was 299 t€ and operating profit 89 t€; equity ratio 99.2 %. Its taxable income in 2024 was 111 t€ and its income taxes 23 t€.
Tampere: 53 new companies in 30 days
- Puhakka Consulting OyRakennuttaminen ja rakennushankkeiden kehittäminen
- Markus Vallinoja Holding OyHoldingyhtiöiden toiminta
- Metsuripalvelu Mähönen OyMetsätaloutta palveleva toiminta
Financials
| Key figures | 31.10.2025 | 31.10.2024 | 31.10.2023 | 31.10.2022 |
|---|---|---|---|---|
| Revenue | 299 t€ | 322 t€ | 324 t€ | 130 t€ |
| Revenue change | -7,2 % | -0,6 % | 149,5 % | – |
| EBITDA | 90 t€ | 111 t€ | 207 t€ | 93 t€ |
| EBITDA % | 30,1 % | 34,5 % | 64,0 % | 71,5 % |
| Operating profit | 89 t€ | 111 t€ | 207 t€ | 93 t€ |
| Operating margin | 29,8 % | 34,5 % | 64,0 % | 71,5 % |
| Net profit | 71 t€ | 89 t€ | 166 t€ | 74 t€ |
| Personnel costs | 139 t€ | 131 t€ | 29 t€ | 4 220 € |
| Equity ratio | 99,2 % | 96,5 % | 98,0 % | 30,1 % |
| Quick ratio | 60,67 | 12,11 | 23,76 | 0,34 |
| Current ratio | 60,67 | 12,11 | 23,76 | 0,34 |
| Debt to revenue | 0,9 % | 3,5 % | 1,5 % | 132,9 % |
| Return on equity | 20,3 % | 29,2 % | 70,8 % | 100,0 % |
| Balance sheet total | 354 t€ | 316 t€ | 239 t€ | 247 t€ |
| Equity | 351 t€ | 304 t€ | 234 t€ | 74 t€ |
| Cash and bank | 128 t€ | 122 t€ | 114 t€ | 58 t€ |
Balance sheet
Income statement and balance sheet
Income statement
| 31.10.2025 | 31.10.2024 | 31.10.2023 | 31.10.2022 | |
|---|---|---|---|---|
| Turnover | 299 t€ | 322 t€ | 324 t€ | 130 t€ |
| Other operating income | 6 713 € | 5 598 € | 4 976 € | 4 356 € |
| Raw materials and services | -279 € | 0 € | -780 € | -247 € |
| Personnel expenses | -139 t€ | -131 t€ | -29 t€ | -4 220 € |
| Depreciations and reductions in value | -958 € | 0 € | – | – |
| Other operating expenses | -77 t€ | -86 t€ | -92 t€ | -37 t€ |
| Operating profit (loss) | 89 t€ | 111 t€ | 207 t€ | 93 t€ |
| Financial income and expenses + (-) | -125 € | 65 € | -29 € | 0 € |
| Profit (loss) before appropriations and taxes | 89 t€ | 111 t€ | 207 t€ | 93 t€ |
| Income taxes | -18 t€ | -22 t€ | -41 t€ | -19 t€ |
| Profit (loss) for the financial year | 71 t€ | 89 t€ | 166 t€ | 74 t€ |
Balance sheet
| 31.10.2025 | 31.10.2024 | 31.10.2023 | 31.10.2022 | |
|---|---|---|---|---|
| Non-current assets | 183 t€ | 180 t€ | 125 t€ | 189 t€ |
| Receivables | 27 t€ | 5 € | 0 € | 0 € |
| Cash in hand and at banks | 128 t€ | 122 t€ | 114 t€ | 58 t€ |
| Current assets | 171 t€ | 135 t€ | 114 t€ | 58 t€ |
| Assets | 354 t€ | 316 t€ | 239 t€ | 247 t€ |
| Capital and reserves | 351 t€ | 304 t€ | 234 t€ | 74 t€ |
| Short-term liabilities | 2 820 € | 11 t€ | 4 792 € | 173 t€ |
| Liabilities | 2 820 € | 11 t€ | 4 792 € | 173 t€ |
All financial statement items (42)
| 31.10.2025 | 31.10.2024 | 31.10.2023 | 31.10.2022 | |
|---|---|---|---|---|
| Turnover | 299 t€ | 322 t€ | 324 t€ | 130 t€ |
| Other operating income | 6 713 € | 5 598 € | 4 976 € | 4 356 € |
| Raw materials and services | -279 € | 0 € | -780 € | -247 € |
| Personnel expenses | -139 t€ | -131 t€ | -29 t€ | -4 220 € |
| Depreciations and reductions in value | -958 € | 0 € | – | – |
| Other operating expenses | -77 t€ | -86 t€ | -92 t€ | -37 t€ |
| Operating profit (loss) | 89 t€ | 111 t€ | 207 t€ | 93 t€ |
| Financial income and expenses + (-) | -125 € | 65 € | -29 € | 0 € |
| Profit (loss) before appropriations and taxes | 89 t€ | 111 t€ | 207 t€ | 93 t€ |
| Income taxes | -18 t€ | -22 t€ | -41 t€ | -19 t€ |
| Profit (loss) for the financial year | 71 t€ | 89 t€ | 166 t€ | 74 t€ |
| Non-current assets | 183 t€ | 180 t€ | 125 t€ | 189 t€ |
| Receivables | 27 t€ | 5 € | 0 € | 0 € |
| Cash in hand and at banks | 128 t€ | 122 t€ | 114 t€ | 58 t€ |
| Current assets | 171 t€ | 135 t€ | 114 t€ | 58 t€ |
| Assets | 354 t€ | 316 t€ | 239 t€ | 247 t€ |
| Capital and reserves | 351 t€ | 304 t€ | 234 t€ | 74 t€ |
| Short-term liabilities | 2 820 € | 11 t€ | 4 792 € | 173 t€ |
| Liabilities | 2 820 € | 11 t€ | 4 792 € | 173 t€ |
| Other shares, financial securities | 16 t€ | 13 t€ | 0 € | – |
| Profit (loss) for the period, equity | 71 t€ | 89 t€ | 166 t€ | 74 t€ |
| Shares and holdings | 16 t€ | 13 t€ | 0 € | – |
| Machinery and equipment | 2 872 € | 0 € | – | – |
| Other shares and similar rights of ownership | 180 t€ | 180 t€ | 125 t€ | 189 t€ |
| Pension expenses | -11 t€ | -14 t€ | -9 217 € | -4 220 € |
| Short-term accounts payable | 0 € | 2 159 € | 0 € | – |
| Liabilities | 354 t€ | 316 t€ | 239 t€ | 247 t€ |
| Short-term prepayments and accrued income | 26 t€ | 0 € | – | – |
| Other interest and financial income from non-group companies | 194 € | 119 € | 1 € | 0 € |
| Short-term accrued expenses and deferred income | 278 € | 3 752 € | 1 525 € | 6 693 € |
| Interest expenses and other financial expenses for non-Group companies | -339 € | -55 € | -30 € | 0 € |
| Other current liabilities | 2 542 € | 5 279 € | 3 268 € | 166 t€ |
| Short-term receivables | 27 t€ | 5 € | 0 € | 0 € |
| Other short-term receivables | 1 825 € | 5 € | 0 € | 0 € |
| Retained earnings | 280 t€ | 215 t€ | 68 t€ | 0 € |
| Income from other investments under non-current assets, from other companies | 20 € | 0 € | – | – |
| Investments | 180 t€ | 180 t€ | 125 t€ | 189 t€ |
| Depreciations according to plan | -958 € | 0 € | – | – |
| Tangible assets | 2 872 € | 0 € | – | – |
| Purchases during the financial year | -279 € | 0 € | -780 € | -247 € |
| Other social security expenses | -5 096 € | -2 190 € | -1 135 € | 0 € |
| Wages and salaries | -123 t€ | -114 t€ | -19 t€ | 0 € |
From financial statements filed digitally (XBRL) with the Finnish Patent and Registration Office; ratios calculated from them. Equity ratio = (equity + accumulated appropriations) / (balance sheet total − advances received).
Taxes
Measured by taxable income, AJH Terveys Oy is in the upper half of the industry class medical specialists activities (2077 companies with taxable income; median 81 t€).
Taxable income is the profit as calculated for taxation, not revenue. Public data from the Finnish Tax Administration; figures for 2025 are published in November 2026.